DAW1: A Drug Target / Disease Biomarker (G164781)

Target Name: DAW1

NCBI ID: G164781

DAW1

DAW1: A Drug Target / Disease Biomarker

DAW1, also known as decorin, is a protein that is expressed in various tissues throughout the body. It is a member of the tight junction gene family, which is responsible for the regulation of cell-cell adhesion. DAW1 has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The tight junction gene family consists of several related genes, including cadherins, which are transmembrane proteins that play a central role in cell-cell adhesion. These genes are involved in the regulation of cell-cell interactions, as well as the maintenance of tissue structure and the development of organs.

DAW1 is a member of the tight junction gene family and is expressed in various tissues throughout the body. It is highly conserved and has a similar structure to other members of the tight junction gene family. DAW1 is involved in the regulation of cell-cell adhesion and has been implicated in various physiological processes, including the development and maintenance of tissues and organs, as well as the regulation of cell growth and differentiation.

DAW1 has been identified as a potential drug target for various diseases. One of the main reasons for its potential as a drug target is its involvement in the regulation of cell-cell adhesion. Many diseases, including cancer, are characterized by the formation of uncontrolled cell-cell junctions, which can lead to the development of tumors. By targeting DAW1, researchers may be able to disrupt these uncontrolled cell-cell junctions and inhibit the growth and progression of cancer cells.

In addition to its potential as a drug target, DAW1 has also been identified as a biomarker for various diseases. Its expression has been observed in a variety of tissues and has been associated with the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. By studying the expression of DAW1, researchers may be able to identify new biomarkers for these diseases and develop new treatments.

The tight junction gene family is a complex group of genes that are involved in the regulation of cell-cell adhesion. DAW1 is a member of this family and is involved in the regulation of cell-cell adhesion. Its expression has been observed in various tissues and has been associated with the development and progression of various diseases. As a result, DAW1 makes an attractive target for researchers who are interested in the development of new treatments for these diseases.

Protein Name: Dynein Assembly Factor With WD Repeats 1

Functions: May play a role in axonemal outer row dynein assembly

The "DAW1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DAW1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets